Disclosure, Objective

35
Rational Use of Rheumatologic Lab Tests: aka “Choosing Wisely” Maryland ACP Scientific Meeting David B. Hellmann, M.D., M.A.C.P. Johns Hopkins Bayview January 31, 2014

description

Rational Use of Rheumatologic Lab Tests: aka “Choosing Wisely” Maryland ACP Scientific Meeting David B. Hellmann, M.D., M.A.C.P . Johns Hopkins Bayview January 31, 2014. Disclosure, Objective. Disclosure: none Objective: - PowerPoint PPT Presentation

Transcript of Disclosure, Objective

Page 1: Disclosure,  Objective

Rational Use of Rheumatologic Lab Tests:aka “Choosing Wisely”

Maryland ACP Scientific Meeting

David B. Hellmann, M.D., M.A.C.P.Johns Hopkins BayviewJanuary 31, 2014

Page 2: Disclosure,  Objective

2

Disclosure, ObjectiveDisclosure: noneObjective:

◦To use a case-based approached to discuss wise use of laboratory tests in rheumatic diseases

Methods—Accenting … Choosing Wisely, Cases, and Differential Diagnosis

Page 3: Disclosure,  Objective

Published simultaneously in 2002 in Annals of Internal

Medicine, The Lancet and the European Journal of

Internal Medicine Charter articulated 3 principles1. Primacy of the patient2. Autonomy of the patient3. Social justice

◦ Includes aspiring to be good stewards of society’s resources

Medical Professionalism in the New Millennium: A Physician

Charter

Page 4: Disclosure,  Objective

1. Don’t test ANA sub-serologies without a positive ANA and clinical suspicion of immune-mediated disease.

2. Don’t test for Lyme disease as a cause of musculoskeletal symptoms without an exposure history and appropriate exam findings

3. Don’t perform MRI of peripheral joints to routinely monitor inflammatory arthritis

Choosing Wisely: ACR Top 5

Page 5: Disclosure,  Objective

4. Don’t prescribe biologics for rheumatoid arthritis before a trial of methotrexate (or other conventional non-biologic DMARDs)

5. Don’t routinely repeat DXA scans more often than once every two years

Choosing Wisely: ACR Top 5

Page 6: Disclosure,  Objective

1. Don’t do imaging for low back pain within the first 6 weeks, unless red flags are present

2. Don’t use DEXA screening for osteoporosis in women < 65 or men < 70 with no risk factors.

AAFP Choosing Wisely

Page 7: Disclosure,  Objective

7

Case PresentationCC: 42 y.o. man with acute LBPHPI: Moved office 48 hrs ago Awoke with acute LBP; worse with activity, better with rest. Naprosyn helps some.ROS: No fever, weakness, bowel/bladder sxsPMH: negativeExamination: VS normal; tenderness LB; neuro exam (-)

What tests should you order?

Page 8: Disclosure,  Objective

8

Red Flags for LBP:AHRQ Criteria for X-ray for Acute LBP Possible fracture

◦ Major trauma, minor trauma > age 50◦ Long-term corticosteroid use◦ Osteoporosis◦ Age > 70

Possible Tumor or Infection◦ Age > 50, < 20◦ History of cancer, injection drug use,recent bacterial

infection, constitutional symptoms, immunosuppression

◦ Pain when supine or at night

Page 9: Disclosure,  Objective

9

Case PresentationCC: 78 y.o woman with headacheHPI: 2 months fatigue, malaise, 5 lb weight loss 1 month of intermittent dull headachePMH: hypertension, osteoarthritisROS: occasional jaw painMedications: HCTZ, acetaminophenPE: 36.8 145/83 84 paleLabs: Hct 32, WBC 6,700 Platelets 532k CMP-nl ESR 105

Page 10: Disclosure,  Objective

10

Erythrocyte Sedimentation Rate (ESR)

Ancient Methods: Westergren, Wintrobe Inexpensive Uses:

◦ Not diagnostic of any disease◦ Supports diagnosis of GCA, PMR, Osteomyelitis◦ Helpful in monitoring (GCA, PMR, RA,

Osteomyelitis)

Page 11: Disclosure,  Objective

Erythrocyte Sedimentation Rate

Page 12: Disclosure,  Objective

12

Erythrocyte Sedimentation Rate (ESR)

Influenced by concentration of [asymmetric particles] = fibrinogen

Requires fresh sample Normal values <20 mm

◦ But affected by age (5/decade), gender, hematocrit, red cell morphology, many plasma proteins, medications (heparin)

Page 13: Disclosure,  Objective

Giant Cell Arteritis: Accuracy of History, PE, LABSymptom (+) LR (-) LRJaw claudication 4.2 (2.8-6.2) 0.72 (.57-.81)Diplopia 3.4 (1.3-8.6) 0.95 (.91-.99)Beaded TA 4.6 (1.1-18.4) 0.93 (.88-.99)Any TA abnl 2.0 (1.4-3) 0.53 (.38-.75)ESR abnl 1.1 (1-1.2) 0.2 (.08-.51)

JAMA 2002;101:287-292

Page 14: Disclosure,  Objective

Giant cell Arteritis with Low ESR Salvarani C, Hunder G. Arthritis Rheum 2001

9 (5%)# with ESR < 40 mm/hr

18 (11%)# with ESR < 50 mm/hr

167Total GCA patients

(1950-1998)

N

Page 15: Disclosure,  Objective

15

ESR: Frequently Asked Questions

1. Can the ESR be normal in GCA?Yes

2. Does a ESR > 100 have special significance?

Maybe3. In an older person with >100 ESR and no

obvious disease other than GCA, what else should I consider?

Multiple Myeloma

Page 16: Disclosure,  Objective

16

ESR Frequently Asked Questions

1. What gives false positives?Pregnancy, multiple myeloma, oral

contraceptives, MGUS

2. What gives false negatives? Polymyositis. Cryoglobulinemia,

congestive heart failure

Page 17: Disclosure,  Objective

17

ESR: Frequently Asked Questions

1. Can the ESR be used as a screening test to determine if a patient with vague symptoms is sick?

Not known!Only 31% of patients with gastric cancer have

ESR > 20

2. What’s the maximum ESR a person can have?

200 – (2 x Hct)3. Is CRP better than ESR?

Page 18: Disclosure,  Objective

18

Case Presentation CC: 19 y.o. AA woman polyarthralgia, feverHPI: 5 wks polyarthralgia, fever, malar rash, pleuritic chest pain, nocturia, ankle swellingFH: Mother had SLEPMH: negativeMeds: ibuprofenPE: T=37.9, malar erythema, alopecia, edemaLabs: Hct 32, WBC 2.7 Platelets 110k Creatinine 1.2Albumin 3.2, Urine 3+ protein, RBC casts, BC/RPR -

What autoantibodies should you order?

Page 19: Disclosure,  Objective

19

ANA: Commonly Asked QuestionsWhat is a positive ANA? 1-10% of well people have ANA >1:80 20 of “sick” people have ANA>1:80What is value of ANA? negative ANA excludes SLE; no value monitoringWhat autoantibodies are specific for SLE? ds-DNA antibodies 99% specific; sensitivity 50% anti-SM specific (95%); sensitivity 30% low Complement: specificity ~90%, sensitivity 50%

Page 20: Disclosure,  Objective

20

ANA PrevalenceDisorder % (+) ANASLE 99RA 30-50Fibromyalgia 20Multiple Sclerosis 20Thyroid disease 40

Page 21: Disclosure,  Objective

21

Case PresentationCC: 24 y.o. woman with polyarthritisHPI: 5 wks polyarthritis mcps, pips, wrists, knees 2 hrs morning stiffness; fatigueROS: (-) fever, weight loss, rash, weakness, chest pain, back pain, travel, tick exposure, neuropathyFH: negative Meds: naproxenPE: polyarthritis; no nodulesLabs: Hct 35, ESR 58, CMP/UA negative

What autoantibodies should you order?

Page 22: Disclosure,  Objective

22

Rheumatoid Arthritis:Diagnostic Tests

TEST Sensitivity Specificity

RF 40-90% 40-90%

Anti-CCP 70-80% 85-95%

RF = rheumatoid factorAnti-CCP = anti-cyclic citrillinated

peptide

Page 23: Disclosure,  Objective

23

Differential Diagnosis Polyarthritis:If Host

Is a 26 year old day care worker with faint, diffuse rash?

Is a 55 year old smoker with new clubbing? Is a 49 year old with large joint arthritis and

red eye? Is 34 year injection drug user with recurrent

purpura?

Page 24: Disclosure,  Objective

24

Case PresentationCC: 46 yo man oligoarthralgia, nasal stuffinessHPI: 3 months oligoarthralgia knees, shoulders nasal stuffiness, crusting, bleeding red eye, cough, fever, hearing loss left earPMH: negativeSH: no cocainePE: scleritis, nasal crusting, otitis media, no joint effusionLabs: Hct 41, WBC 11k, Creatinine 1.6, urine 10-15 RBC’s; Chest CT: multiple nodules

What autoantibodies should you order?

Page 25: Disclosure,  Objective
Page 26: Disclosure,  Objective

ANCA Patterns and Associations

Pattern Antigen DiseaseC-ANCA proteinase-3 GPA

P-ANCA myeloperoxidase MPA* Churg-Strauss

Drug-induced

GPA= granulomatosis with polyangiitis*MPA = microscopic polyangiitis

Page 27: Disclosure,  Objective

Cocaine Induced Midline Destructive Lesions

Page 28: Disclosure,  Objective

Levamisole Vasculitis

Page 29: Disclosure,  Objective

29

Summary Choosing wisely is part of professionalism Avoid ordering imaging for acute LBP unless

red flags are present Most blood tests in rheumatology should be

ordered when the probability of disease is intermediate

Don’t test ANA sub-serologies without a positive ANA and clinical suspicion

Page 30: Disclosure,  Objective

30

CRP Levels

< 1 mg/dl 1-10 mg/dl >10 mg/dlNormal MI bacterial INFPregnancy CTD vasculitisDepressionObesityGingivitis

Page 31: Disclosure,  Objective

31

ANCA Do IF first; confirm result with ELISA C-ANCA = anti-PR3 = GPA P-ANCA = anti-MPO = GPA, MPA etc “Atypical” ANCA = anti-Lactoferin, etc = IBD Cocaine, levamisole can cause vasculitis

with positive C-ANCA, P-ANCA

Page 32: Disclosure,  Objective
Page 33: Disclosure,  Objective

33

CRP vs ESR C-Reactive Protein (CRP) is an acute phase

protein whose concentration reflects level of inflammation

Unaffected by age (?), gender, monoclonal antibodies; fresh sample not required

Quantification is precise; wide range of clinically relevant values

May be more sensitive than ESR in GCA, PMR

Page 34: Disclosure,  Objective

ANCA

Disease Sensitivity SpecificityGPA 70-90% 30-

90%?

MPA 70-90% 30-80%

GPA= granulomatosis with polyangiitis*MPA = microscopic polyangiitis

Page 35: Disclosure,  Objective

c-ANCA p-ANCA